echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: Evaluation of the effectiveness of BNT162b2 mRNA vaccine after mass vaccination in Israel

    NEJM: Evaluation of the effectiveness of BNT162b2 mRNA vaccine after mass vaccination in Israel

    • Last Update: 2021-03-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, researchers investigated the effectiveness of the BNT162b2 mRNA vaccine after mass vaccination in Israel.
    Recently, researchers investigated the effectiveness of the BNT162b2 mRNA vaccine after mass vaccination in Israel.
    Infections 14-20 days after the first vaccination, and at least 7 days after the second vaccination, the endpoint event data for the vaccinated vs.
    unvaccinated population is as follows: SARS-COV-2 infection, 46% vs 92%; symptomatic Covid-19, 57% vs 94%; Covid-19 hospitalization, 74% vs 87%; severe Covid-19, 62% vs 92%.
    14-20 days after the first vaccination, and at least 7 days after the second vaccination, the endpoint event data for the vaccinated vs.
    unvaccinated population is as follows: SARS-COV-2 infection, 46% vs 92%; symptomatic Covid -19, 57% vs 94%; Covid-19 hospitalization, 74% vs 87%; severe Covid-19, 62% vs 92%.
    Coronavirus disease
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.